Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

AstraZeneca PLC ADR

0A4J
Current price
64.19 USD +0.24 USD (+0.37%)
Last closed 63.85 USD
ISIN US0463531089
Sector Healthcare
Industry Drug Manufacturers - General
Exchange London Exchange
Capitalization 203 143 249 920 USD
Yield for 12 month +1.83 %
1Y
3Y
5Y
10Y
15Y
0A4J
21.11.2021 - 28.11.2021

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom. Address: 1 Francis Crick Avenue, Cambridge, United Kingdom, CB2 0AA

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

91.03 USD

P/E ratio

30.9951

Dividend Yield

2.3 %

Current Year

+45 811 000 000 USD

Last Year

+44 351 000 000 USD

Current Quarter

+12 938 000 000 USD

Last Quarter

+12 938 000 000 USD

Current Year

+37 543 000 000 USD

Last Year

+31 960 000 000 USD

Current Quarter

+9 793 000 000 USD

Last Quarter

+9 793 000 000 USD

Key Figures 0A4J

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 16 972 999 680 USD
Operating Margin TTM 22.42 %
PE Ratio 30.9951
Return On Assets TTM 7.68 %
PEG Ratio 0.7134
Return On Equity TTM 16.74 %
Wall Street Target Price 91.03 USD
Revenue TTM 49 132 998 656 USD
Book Value 25.49 USD
Revenue Per Share TTM
Dividend Share 2.97 USD
Quarterly Revenue Growth YOY 13.3 %
Dividend Yield 2.3 %
Gross Profit TTM 35 732 000 000 USD
Earnings per share 2.06 USD
Diluted Eps TTM 2.06 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 6 %
Profit Margin 13.11 %

Dividend Analytics 0A4J

Dividend growth over 5 years

6 %

Continuous growth

1 year

Payout Ratio 5 years average

834 %

Dividend History 0A4J

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 1.49
Ex Dividend Date 09.08.2024
Forward Annual Dividend Yield 2.33 %
Last Split Factor 2:1
Payout Ratio 54 %
Last Split Date 27.07.2015
Dividend Date 09.09.2024

Stock Valuation 0A4J

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 30.9951
Forward PE 13.624
Enterprise Value Revenue 4.7004
Price Sales TTM 4.1346
Enterprise Value EBITDA 16.3955
Price Book MRQ 5.0097

Financials 0A4J

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 0A4J

For 52 weeks

59.19 USD 87.68 USD
50 Day MA 78.44 USD
Shares Short Prior Month 5 388 764
200 Day MA 74.84 USD
Short Ratio 1.14
Shares Short 4 027 866
Short Percent 0.27 %